Thompson Davis & Co., Inc. Codexis, Inc. Transaction History

Thompson Davis & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $431,528 - $703,993	-16,850 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.35 - $19.1 $3,337 - $4,775	-250 Reduced 1.46%	16,850 $289,000
Q2 2018 Aug 03, 2018	BUY	$10.35 - $16.45 $20,700 - $32,900	2,000 Added 13.25%	17,100 $246,000
Q1 2018 May 02, 2018	SELL	$8.0 - $12.8 $27,480 - $43,968	-3,435 Reduced 18.53%	15,100 $166,000
Q4 2017 Feb 05, 2018	BUY	$5.85 - $8.4 $102,579 - $147,294	17,535 Added 1753.5%	18,535 $155,000
Q3 2017 Oct 30, 2017	BUY	$4.9 - $6.65 $4,900 - $6,650	1,000	1,000 $7,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.